Tokyo, June 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000057948) titled 'Safety Confirmation Study on Overdose of Supplement Containing Bee Larva in Healthy Subjects' on May 26

Study Type:

Interventional

Study Design:

Basic Design - Single arm Randomization - Non-randomized Blinding - Open -no one is blinded Control - Uncontrolled

Primary Sponser:

Institute - Yamada Bee Company, Inc.

Condition:

Condition - Healthy Adult Classification by malignancy - Others Genomic information - NO

Objective:

Intervention:

Interventions/Control_1 - Capsule-type supplement containing bee larva and trace amounts of royal jelly ingredients Intake amount: 20 grains/day Intake duration: 28 days Elig...